Institutional Owners May Ignore ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$67m Market Cap Decline as Longer-term Profits Stay in the Green

Yahoo FinanceDec 24 23:24

ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies

BenzingaDec 20 06:29

ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies

GlobeNewswireDec 20 06:25

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18 21:00

ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia

BenzingaDec 13 03:35

ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

SECDec 7 05:10 · Announcements